Four patients who developed a clinical syndrome characterized by hyperpigmentation of the skin, weakness, fatigue, weight loss, anorexia and nausea while on long-term treatment with busulfan were described. The etiology of the disorder, although clearly related to the busulfan therapy, is obscure, but may be related to "dethiolation".

This content is only available as a PDF.